People: Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,108.00GBp
22 Dec 2014
Price Change (% chg)

19.00p (+1.75%)
Prev Close
1,089.00p
Open
1,100.00p
Day's High
1,119.00p
Day's Low
1,098.00p
Volume
1,668,849
Avg. Vol
2,842,162
52-wk High
1,198.00p
52-wk Low
850.00p

Search Stocks

Summary

Name Age Since Current Position

Roberto Quarta

64 2014 Non-Executive Independent Chairman of the Board

Olivier Bohuon

55 2011 Chief Executive Officer, Executive Director

Julie Brown

51 2013 Chief Financial Officer, Executive Director

Rodrigo Bianchi

54 2013 President, IRAMEA

Michael Frazzette

52 2011 President - Advanced Surgical Devices

R. Gordon Howe

51 2013 President - Global Operations

Roger Teasdale

46 2009 President - Advanced Wound Management

Francisco Vega

52 2013 President - Latin America

John Campo

59 2008 Chief Legal Officer

Helen Maye

54 2011 Chief Human Resources Officer

Cyrille Petit

43 2012 Chief Corporate Development Officer

Susan Swabey

51 2009 Company Secretary

Vinita Bali

58 2014 Non-Executive Director

Ian Barlow

62 2010 Non-Executive Independent Director

Virginia Bottomley

66 2012 Non-Executive Independent Director

Michael Friedman

70 2013 Non-Executive Independent Director

Brian Larcombe

61 2014 Senior Independent Non-Executive Director

Joseph Papa

58 2008 Non-Executive Independent Director

Kim Gunthorp

Investor Relations Manager

Biographies

Name Description

Roberto Quarta

Mr. Roberto Quarta serves as Non-Executive Independent Chairman of the Board of Smith & Nephew PLC., effective April 10, 2014. He was appointed Non-executive Director and Chairman Elect on 4 December 2013. He is a member of the Nomination & Governance Committee. He has significant management experience spanning a broad range of manufacturing and service businesses in both the UK and internationally. He is Chairman of IMI plc, a FTSE 100 listed engineering business, Chairman of Clayton, Dubilier & Rice and Chairman of the Supervisory Board of Rexel SA. Previously, he was Chief Executive and then Chairman of BBA Group plc.

Olivier Bohuon

Mr. Olivier Bohuon is Chief Executive Officer, Executive Director of Smith and Nephew PLC. He is a member of the Nomination & Governance Committee. He has had extensive international and leadership experience within a number of pharmaceutical and healthcare companies. Prior to joining Smith & Nephew, he was President of Abbott Pharmaceuticals, a division of Abbott Laboratories based in the US, where he was responsible for the entire business, including R&D, global manufacturing and global support functions.

Julie Brown

Ms. Julie Brown is Chief Financial Officer, Executive Director of Smith & Nephew PLC., since February 4, 2013. She is a Chartered Accountant and Fellow of the Institute of Taxation with international experience and a deep understanding of the healthcare sector. She trained with KPMG and then worked for AstraZeneca PLC, where she served as Vice President Group Finance, and more recently, as Interim Chief Financial Officer. Prior to that she held commercial roles as Regional Vice President Latin America, Marketing Company President AstraZeneca Portugal, and Vice President Corporate Strategy and R&D Chief Financial Officer. She has previously held Vice President Finance positions in all areas of the healthcare value chain including commercial, operations, R&D and business development.

Rodrigo Bianchi

Mr. Rodrigo Bianchi serves as President, IRAMEA of Smith and Nephew PLC. He joined Smith & Nephew in July 2013 with responsibility for Greater China, India, Russia, Asia, Middle East and Africa, focusing on continuing our strong momentum in these regions. He is based in Dubai, his experience in the healthcare industry includes 26 years with Johnson & Johnson in progressively senior roles. Most recently, he was Regional Vice President for Medical Devices and Diagnostics division in the Mediterranean region and prior to that President of Mitek and Ethicon. He started his career at Procter & Gamble, Italy.

Michael Frazzette

Mr. Michael Frazzette is President - Advanced Surgical Devices of Smith & Nephew PLC. He joined Smith & Nephew in July 2006 as President of the Endoscopy Global Business Unit. Since July 2011, he has headed up the Advanced Surgical Devices division and is responsible for the Orthopaedic Reconstruction, Trauma and Endoscopy business. He is based in Andover, Massachusetts. He has held a number of senior positions within the global medical devices industry. He was President and Chief Executive Officer of Micro Group, a US manufacturer of medical devices, and spent 15 years at Tyco Healthcare (Covidien) in various commercial roles eventually becoming President of the Patient Care and Health Systems divisions.

R. Gordon Howe

Mr. R. Gordon Howe is President - Global Operations of Smith & Nephew PLC. He is responsible for manufacturing, supply chain and procurement, IT systems and Regulatory and Quality Affairs. Prior to that, he headed up the Global Planning and Business Development teams. He is based in Memphis, Tennessee. He has held a number of senior management positions within the Smith & Nephew Group, firstly in the Orthopaedics division and more recently at Group level. Prior to joining the Company, he held senior roles at United Technologies Corporation

Roger Teasdale

Mr. Roger Teasdale is President - Advanced Wound Management of Smith & Nephew PLC., since May 2009. He joined Smith & Nephew in 1989 within the Wound Management business. He was appointed President of Advanced Wound Management in May 2009. He is based in Hull, UK. He has held a number of key roles within the Smith & Nephew Group in both the UK and the US and has been responsible for leading the transformation of the Wound business in recent years.

Francisco Vega

Mr. Francisco Canal Vega is President - Latin America of Smith and Nephew PLC. He joined Smith & Nephew in January 2012 and now leads the Latin American region, focusing on driving the substantial opportunities. He has held senior management positions in global companies including Gambro AB and Baxter International. He has lived and worked in many countries including Switzerland, Germany, China, Japan, the US and Spain. He was also formerly a board member of EUCOMED.

John Campo

Mr. John W. Campo is Chief Legal Officer of Smith & Nephew PLC. He joined Smith & Nephew in June 2008 and heads up the Global Legal function. Initially based in London, he has been based in Andover, Massachusetts since late 2011. Prior to joining Smith & Nephew, Jack held a number of senior legal roles within the General Electric Company, including seven years at GE Healthcare (GE Medical Systems) in the US and Asia. He began his career with Davis Polk & Wardwell.

Helen Maye

Ms. Helen Maye is Chief Human Resources Officer of Smith & Nephew PLC. She joined Smith & Nephew in July 2011 and leads the Global Human Resources and Internal Communications functions. Since 2013, she has also led the Sustainability, Health, Safety & Environment functions. She is based in London. She has more than 35 years’ experience across a variety of international and global roles in medical devices and Pharmaceuticals, including manufacturing, supply chain and human resources. Previously, she was Divisional Vice President of Human Resources at Abbott Laboratories.

Cyrille Petit

Mr. Cyrille Petit is Chief Corporate Development Officer of Smith & Nephew PLC., since May 2012. He spent the previous 15 years of his career with General Electric Company, where he held progressively senior positions beginning with GE Capital, GE Healthcare and ultimately as the General Manager, Global Business Development of the Transportation Division. Cyrille’s career began in investment banking at BNP Paribas and then Goldman Sachs.

Susan Swabey

Ms. Susan Swabey is Company Secretary of Smith & Nephew PLC., since May 2009. She has nearly 30 years’ experience as a company secretary in a wide range of companies including Prudential plc, Amersham plc and RMC Group plc. Her work has covered Board support, corporate governance, corporate transactions, share registration, listing obligations, corporate social responsibility, pensions, insurance and employee and executive share plans. Susan is a member of the GC100 Group Executive Committee and the CBI Companies Committee and is a frequent speaker on corporate governance related matters.

Vinita Bali

Ms. Vinita Bali has been appointed as Non-Executive Director of the Company, effective 1 December 2014. Bali is currently a Non-Executive Director of Syngenta AG, Titan Company Ltd and CRISIL (Credit Rating Information Services of India) Ltd. She is also a Director of GAIN (Global Alliance for Improved Nutrition). Bali was most recently Managing Director and Chief Executive Officer of Britannia Industries Ltd, a leading Indian publically listed food company (2005-2014). She started her career in India with the Tata Group, and then, in 1980, joined Cadbury India, subsequently working for Cadbury in the UK, Nigeria and South Africa. From 1994 onwards, she held a number of senior global positions in marketing and general management at The Coca-Cola Company based in the USA and South America, becoming President of the Andean Division in 1999 and Vice-President, Corporate Strategy in 2001. In 2003 she joined the consultancy Zyman Group as Managing Principal based in the USA. Vinita Bali holds an MBA from The Jamnalal Bajaj Institute of Management Studies, University of Bombay and a bachelor's degree in economics from the University of Delhi.

Ian Barlow

Mr. Ian E. Barlow is Non-Executive Independent Director of Smith & Nephew PLC. Ian was appointed Non-executive Director in March 2010 and Chairman of the Audit Committee in May 2010. Ian is a Chartered Accountant and has had considerable financial experience both internationally and in the UK. Prior to his retirement in 2008, he was a Partner at KPMG, latterly Senior Partner, London. During his career with KPMG, he was Head of their UK tax and legal operations, and he acted as Lead Partner for many large international organisations operating extensively in North America, Europe and Asia.

Virginia Bottomley

The Right Honorable Baroness Virginia Bottomley is Non-Executive Independent Director of Smith & Nephew PLC., since April 12, 2012. She is a member of the Remuneration Committee. She has extensive experience and understanding of healthcare. She was appointed a Life Peer in 2005 following her career as a Member of Parliament between 1984 and 2005. She served successively as Secretary of State for Health and then National Heritage. She holds a number of positions within the public and private healthcare sector.

Michael Friedman

Dr. Michael A. Friedman, M.D., serves as Non-Executive Independent Director of Smith & Nephew PLC., effective April 11, 2013. He was appointed Non-executive Director and elected by Shareholders at the Annual General Meeting on 11 April 2013. He is a member of the Ethics & Compliance Committee. He was formerly Chief Executive Officer of City of Hope, the prestigious cancer research and treatment institution in California and is now Executive for Special Projects and Emeritus Cancer Center Director. He has also served as director of the institution’s comprehensive cancer centre and held the Irell & Manella Cancer Center Director’s Distinguished Chair. He was formerly senior vice president of research, medical and public policy for Pharmacia Corporation and has served as Deputy Commissioner and Acting Commissioner at the US Food and Drug Administration. He has also served on a number of Boards in a Non-executive capacity, including RiteAid Corporation.

Brian Larcombe

Mr. Brian Paul Larcombe has been appointed as Senior Independent Non-Executive Director of Smith & Nephew PLC., effective April 10, 2014. He was appointed Non-executive Director in March 2002. He is a member of the Nomination & Governance, Audit and Remuneration Committees. He will become Senior Independent Director following the Annual General Meeting on 10 April 2014. He spent his career in private equity with 3i Group. After leading the UK investment business for a number of years, he became Finance Director and then Chief Executive of the Group following its flotation. He is well known in the City and has held a number of Non-executive Directorships.

Joseph Papa

Mr. Joseph C. Papa is Non-Executive Independent Director of Smith & Nephew PLC. He was appointed Non-executive Director in August 2008 and Chairman of the Remuneration Committee in April 2011. He is a member of the Ethics & Compliance and Audit Committees. He has had over 30 years’ experience in the pharmaceutical industry working for a number of companies both in the US and Switzerland. He is now Chairman and Chief Executive of Perrigo Company plc, one of the largest over the counter pharmaceutical companies in the US, having previously held senior positions at Novartis International AG, Cardinal Health, Inc. and Pharmacia Corporation.

Kim Gunthorp

Search Stocks